Cizzle Biotechnology (UK) Buy Hold or Sell Recommendation
| CIZ Stock | 1.80 0.10 5.26% |
Assuming the 90 days trading horizon and your way above-average risk tolerance, our recommendation regarding Cizzle Biotechnology Holdings is 'Strong Sell'. Macroaxis provides Cizzle Biotechnology buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding CIZ positions.
Check out Cizzle Biotechnology Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Cizzle and provide practical buy, sell, or hold advice based on investors' constraints. Cizzle Biotechnology Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
Cizzle |
Execute Cizzle Biotechnology Buy or Sell Advice
The Cizzle recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Cizzle Biotechnology Holdings. Macroaxis does not own or have any residual interests in Cizzle Biotechnology Holdings or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Cizzle Biotechnology's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Modest | Details | |
Volatility | Dangerous | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Moves indifferently to market moves | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Cizzle Biotechnology Trading Alerts and Improvement Suggestions
| Cizzle Biotechnology may become a speculative penny stock | |
| Cizzle Biotechnology had very high historical volatility over the last 90 days | |
| Net Loss for the year was (1.76 M) with profit before overhead, payroll, taxes, and interest of 25 K. | |
| Cizzle Biotechnology generates negative cash flow from operations | |
| About 44.0% of the company shares are held by company insiders | |
| Latest headline from news.google.com: Promising UK Penny Stocks To Watch In November 2024 - Simply Wall St |
Cizzle Biotechnology Returns Distribution Density
The distribution of Cizzle Biotechnology's historical returns is an attempt to chart the uncertainty of Cizzle Biotechnology's future price movements. The chart of the probability distribution of Cizzle Biotechnology daily returns describes the distribution of returns around its average expected value. We use Cizzle Biotechnology Holdings price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Cizzle Biotechnology returns is essential to provide solid investment advice for Cizzle Biotechnology.
| Mean Return | 0.30 | Value At Risk | -4.76 | Potential Upside | 7.50 | Standard Deviation | 3.95 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Cizzle Biotechnology historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Cizzle Biotechnology Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | (7.1K) | (294K) | 868K | (397K) | (334K) | (317.3K) | |
| Free Cash Flow | (7.1K) | (294K) | (1.2M) | (872K) | (639K) | (671.0K) | |
| Other Non Cash Items | (2K) | (12K) | 2.8M | 81K | 828K | 869.4K | |
| Net Income | (21.7K) | (306K) | (4.0M) | (963K) | (1.8M) | (1.9M) | |
| End Period Cash Flow | 12.8K | 84K | 875K | 478K | 144K | 136.8K |
Cizzle Biotechnology Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Cizzle Biotechnology or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Cizzle Biotechnology's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Cizzle stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.31 | |
β | Beta against Dow Jones | -0.18 | |
σ | Overall volatility | 4.02 | |
Ir | Information ratio | 0.04 |
Cizzle Biotechnology Volatility Alert
Cizzle Biotechnology Holdings shows above-average downside volatility for the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Cizzle Biotechnology's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Cizzle Biotechnology's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Cizzle Biotechnology Fundamentals Vs Peers
Comparing Cizzle Biotechnology's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Cizzle Biotechnology's direct or indirect competition across all of the common fundamentals between Cizzle Biotechnology and the related equities. This way, we can detect undervalued stocks with similar characteristics as Cizzle Biotechnology or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Cizzle Biotechnology's fundamental indicators could also be used in its relative valuation, which is a method of valuing Cizzle Biotechnology by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Cizzle Biotechnology to competition |
| Fundamentals | Cizzle Biotechnology | Peer Average |
| Return On Equity | -1.58 | -0.31 |
| Return On Asset | -0.32 | -0.14 |
| Current Valuation | 6.32 M | 16.62 B |
| Shares Outstanding | 396.39 M | 571.82 M |
| Shares Owned By Insiders | 43.65 % | 10.09 % |
| Price To Book | 8.99 X | 9.51 X |
| Price To Sales | 200.48 X | 11.42 X |
| Gross Profit | 25 K | 27.38 B |
| EBITDA | (695) | 3.9 B |
| Net Income | (1.76 M) | 570.98 M |
| Total Debt | 186 K | 5.32 B |
| Book Value Per Share | 0 X | 1.93 K |
| Cash Flow From Operations | (639 K) | 971.22 M |
| Earnings Per Share | (0.01) X | 3.12 X |
| Number Of Employees | 4 | 18.84 K |
| Beta | 0.37 | -0.15 |
| Market Capitalization | 7.14 M | 19.03 B |
| Total Asset | 1.69 M | 29.47 B |
| Retained Earnings | (7.87 M) | 9.33 B |
| Working Capital | 1.51 M | 1.48 B |
| Net Asset | 1.69 M |
Cizzle Biotechnology Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Cizzle . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 30788.57 | |||
| Daily Balance Of Power | (0.67) | |||
| Rate Of Daily Change | 0.95 | |||
| Day Median Price | 1.82 | |||
| Day Typical Price | 1.81 | |||
| Price Action Indicator | (0.07) | |||
| Period Momentum Indicator | (0.10) | |||
| Relative Strength Index | 29.34 |
About Cizzle Biotechnology Buy or Sell Advice
When is the right time to buy or sell Cizzle Biotechnology Holdings? Buying financial instruments such as Cizzle Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Cizzle Biotechnology in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Target Outcome ETFs Thematic Idea Now
Target Outcome ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Target Outcome ETFs theme has 93 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Target Outcome ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Cizzle Stock
Cizzle Biotechnology financial ratios help investors to determine whether Cizzle Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cizzle with respect to the benefits of owning Cizzle Biotechnology security.